EUVIMEDEUVIMED entdecken
Crossref

Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population

Mojahed Mohammad K Shalabi, Sahithi Talasila, Hamza Malick, George M Jeha, Stanislav N Tolkachjov

Journal of Drugs in Dermatology · 01.11.2026 · 25 (11) · 1077-1079

DOI: 10.36849/jdd.9785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.10.2026. Verfasst von Mojahed Mohammad K Shalabi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Shalabi, M. M. K., Talasila, S., Malick, H., Jeha, G. M., & Tolkachjov, S. N. (2026). Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population. Journal of Drugs in Dermatology, 25(11), 1077-1079. https://doi.org/10.36849/jdd.9785

Vancouver

Shalabi MMK, Talasila S, Malick H, Jeha GM, Tolkachjov SN. Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population. Journal of Drugs in Dermatology. 2026;25(11):1077-1079. doi:10.36849/jdd.9785

BibTeX
@article{Shalabi2026,
  author = {Shalabi, Mojahed Mohammad K and Talasila, Sahithi and Malick, Hamza and Jeha, George M and Tolkachjov, Stanislav N},
  title = {Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population},
  journal = {Journal of Drugs in Dermatology},
  year = {2026},
  volume = {25},
  number = {11},
  pages = {1077--1079},
  doi = {10.36849/jdd.9785}
}
Kostenlos starten →